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INTERRELATIONSHIP BETWEEN RADIOLOGIC
FINDINGS AND PROGNOSIS OF EPILEPSY IN
CHILDREN WITH NEUROCYSTICERCOSIS
Lisiane Seguti Ferreira1, Verônica A. Zanardi2, Li Min Li1, Marilisa M. Guerreiro1
ABSTRACT - Introduction: Epileptic manifestations of Neurocysticercosis (NC) appear to depend on number
and localization of the cysts. The objective of this study was to investigate the relationship between CT
findings, number of parasites and the evolutive stage of the cysts, and the prognosis of epilepsy in children
with NC. Method: We studied 28 patients with the parenchymal form of NC, considering: epilepsy duration;
seizure frequency before and after AED treatment; seizure control; number of AED and recurrence after AED
withdrawal. Clinical information was crossed with the number of lesions and disease activity in univariate
comparison. Results: The analysis of the clinical data in relation to the number of lesions and disease activity
showed no statistical difference among the variables (p>0.05). Conclusion: We conclude that the course of
epilepsy due to NC in childhood cannot be based exclusively on the number or stage of the parasites.
KEY WORDS: neurocysticercosis, childhood epilepsy, radiology, prognosis.
Interrelação entre achados radiológicos e o prognóstico da epilepsia em crianças com neurocisticercose
RESUMO - Introdução: As manifestações epilépticas da neurocisticercose (NC) parecem depender do número
e localização das lesões. O objetivo desse estudo foi investigar a relação entre os achados de CT, número de
parasitas e estágio evolutivo dos cistos, com o prognóstico da epilepsia em crianças. Método: Nós estudamos
28 pacientes com a forma parenquimatosa da NC, considerando: duração da epilepsia; freqüência de crises
antes e após o tratamento com DAE; aquisição de controle; número de drogas e recorrência. Esses aspectos
foram correlacionados com o número de lesões e atividade da doença em análise estatística univariada.
Resultados: A análise dos dados clínicos em relação ao número de lesões e atividade da doença não revelou
diferenças estatisticamente significativas (p>0,05). Conclusão: Concluímos que o curso da epilepsia por NC
na infância não pode se basear exclusivamente no número ou estágio dos parasitas.
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Neurocysticercosis (NC) is a common health prob-
lem in developing countries. It affects patients of all
ages and it is endemic in adults as well as among
children in Latin America1-3. Epilepsy is the most im-
portant clinical manifestation. It occurs in 70-90%
of all children with the parenchymal form of the dis-
ease, usually being its primary presentation4,5 the pa-
thophysiology of the seizures due to NC is not com-
pletely understood yet. In active and transitional
forms, seizures may be the consequence of compres-
sion or inflammatory reaction. In inactive form, pe-
rilesional gliosis is probably the cause of the seizures.
Chronic inflammatory reaction sometimes takes sev-
eral years to disappear and it may have an impor-
tant role in the pathophysiology of focal epilepsy in
NC6,7. Epileptic manifestations appear to depend on
number and localization of the cysts8. Nevertheless,
some studies have not shown any difference both in
seizure frequency and in clinical or electroencepha-
lographic characteristics in patients with a single le-
sion compared to those with multiple lesions 9,10.
The objective of this study was to investigate the
relationship between CT findings, number of para-
sites and the evolutive stage of the cysts, and the
prognosis of epilepsy in children with NC.
METHOD
This was a retrospective study. We selected all patients
with less than 16 years with probable or definitive diag-
nosis for NC according to Del Bruto et al.11. Forty-one pa-
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tients with NC were followed at the Pediatric Epilepsy Out-
patient Clinic at the University of Campinas from January
1983 to January 1999. Five patients had a single seizure
with follow-up of at least 12 months. Eight patients had
the encephalitic form of NC. These 13 patients were exclu-
ded because single seizure is not epilepsy, and the ence-
phalitic form is a more severe presentation of NC with a
tendency for permanent neurological sequelae and severe
epileptic condition than the one habitually found in pa-
tients with epilepsy resulting from NC.
We obtained all information from the remaining 28
patients on revision of their medical records, complemen-
ted with direct interview with patients and guardians whe-
never possible. A semi-structured protocol was filled in
for every patient, considering: epilepsy duration (this was
defined as the period between the first seizure up to the
moment that antiepileptic drugs (AED) were withdrawn
or until the last appointment for patients with persistent
seizures, regardless of any remission period during the
follow-up); seizure frequency before AED treatment was
classified according to the total number of seizures quan-
tified as: A<10, B = 10 to 50, C>50; seizure frequency
after AED introduction (same classification as above) ; sei-
zure control was defined as one year without having sei-
zures; number of AED to obtain seizure control; recurrence
after AED withdrawal (the policy of AED withdrawal was
carried out after two years of seizure-freedom).
All 28 patients had computerized tomography scan
(CT) at the time of the diagnosis in our center. All exams
were revised by one of us (VAZ), a neuroradiologist with
experience with NC. Lesions were counted and classified
into three groups: five or less, between six and 10, and
more than 10. Patients with a single calcification were
excluded from this research. The disease activity was clas-
sified as active (appears on CT as hipodense cyst without
enhancement), transitional (there is a ring or nodular con-
trast enhancement), and inactive (calcified lesions on CT)
based on the viability of the parasite as proposed by Carpio
et al.12. When lesions in different stages were found in the
same patient, they were classified according to the most
active lesion detected.
The clinical information listed above was crossed with
the number of lesions and disease activity in univariate
comparison using Kruskal-Wallis with post hoc pairwise
comparison or Fisher exact test, and significance was as-
sumed when p<0.05.
RESULTS
Twenty-eight patients (16 girls, mean age = 7.2
years, mean follow-up of 64.5 months) had paren-
chymal form of NC and normal neurological exami-
nation and were the subjects of this study.
Concerning the evolutive stage of the parasite,
17 patients were at inactive phase, six at transitional
phase and five children had active lesions on CT.
Regarding number of lesions, 18 patients had five
or less than five lesions, four had between six and
10 lesions, and six had more than 10 cysts.
The statistical analysis of clinical data in relation
to the number of lesions and disease activity showed
the following.
Epilepsy duration: mean duration of epilepsy was
7.2 years (range from 2.3 to 14.1 years). We did not
find any statistical difference when we compared
mean scores of epilepsy duration with stage (Kruskal-
Wallis test p=0.20) and number of lesions (Kruskal-
Wallis test p=0.18). Multiple cysts, regardless of
stage, did not influence epilepsy duration and had
the same behavior as a few lesions.
Seizure frequency: 12 patients had less than 10
seizures, 10 children had seizures between 10 and
50, and six had more than 50 seizures. We did not
find statistical difference when we compared in
univaried analysis seizure frequency with stage and
number of lesions (Table 1).
Seizure frequency after AED treatment: 15 pa-
tients had less than 10 seizures, nine had seizures
between 10 and 50, and four had more than 50 sei-
zures. There was no statistical difference comparing
Table 1. Seizure frequency.
Number of lesions Disease activity
Seizure frequency ≤ 5 5-10 > 10 Active Inactive Transitional
A (< 10) 10 1 1 1 7 4
35.7% 3.5% 3.5% 3.5% 25% 14.3%
B (10-50) 5 2 3 3 5 2
17.9% 7.1% 10.7% 10.7% 18% 7.1%
C (> 50) 3 1 2 1 5 0
10.7% 3.5% 7.1% 3.5% 18%
Seizure frequency and number of lesions Fisher’s exact test p 0.43
Seizure frequency and disease activity Fisher’s exact test p 0.42
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Table 2. Seizure frequency after AED introduction.
Number of lesions Disease activity
Seizure frequency ≤ 5 5-10 > 10 Active Inactive Transitional
A < 10 12 2 1 1 9 5
42.9% 7.1% 3.6% 3.6% 32.1% 17.9%
B 10-50 4 1 4 3 5 1
14.3% 3.6% 14.3% 10.7% 17.9% 3.6%
C > 50 2 1 1 1 3 0
7.1% 3.6% 3.6% 3.6% 10.7%
Seizure frequency after AED and number of lesions Fisher’s exact test p 0.17
Seizure frequency after AED and disease activity Fisher’s exact test p 0.33
Table 3. Number of AEDs.
Number of lesions Disease activity
Number of drugs ≤ 5 5-10 > 10 Active Inactive Transitional
1 8 1 0 1 7 1
28.6% 3.6% 3.6% 25% 3.6%
2 6 0 4 2 4 4
21.4% 14.3% 7.1% 14.3% 14.3%
≥ 3 4 3 2 2 6 1
14.3% 10.7% 7.1% 7.1% 21.4% 3.6%
Number of AED and number of lesions Fisher’s exact test p 0.06
Number of AED and disease activity Fisher’s Exact Test p 0.52
Table 4. Seizure control.
Number of lesions Disease activity
Seizure control ≤ 5 5-10 > 10 Active Inactive Transitional
Yes 17 3 4 3 15 6
n = 24 60.7% 10.7% 14.3% 10.7% 53.6% 21.4%
No 1 1 2 2 2 0
n = 4 3.6% 3.6% 7.1% 7.1% 7.1% 0
Control seizure and number of lesions Fisher’s exact test p 0.16
Control seizure and disease activity Fisher’s exact test p 0.40
in univaried analysis seizure frequency after AED with
stage and number of lesions (Table 2).
Number of AED: nine patients received only one
AED during their treatment, 10 received two AED,
and nine received three or more AED, either isolated
or in association. There was no statistical difference
comparing number of AED with stage and number
of lesions (Table 3).
Seizure control: 24 patients obtained control of
their epilepsy. The mean time to obtain control was
16.1 months. We did not find any difference when
we compared seizure control with the stage and
number of lesions (Table 4).
Recurrence: it occurred in 13 out of 24 evaluated
patients. The mean time to seizure recurrence was 21.4
months, ranging from one to 48 months. There was
no statistical difference when comparing recurrence
with the stage and number of lesions (Table 5).
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DISCUSSION
Neuroimaging has attained enormous progress
during last decade. CT is very helpful in NC because
it is a safe, precise and noninvasive method with
more than 95% accuracy to define number, localiza-
tion and evolutive stages of the parasites, especially
in the parenchymal form of the disease. In develop-
ing countries where MRI machines are not always
available, and considering the fact that calcifications
are the main radiologic finding in NC, CT is still the
most performed and useful examination13-16.
In this study, we tried to correlate CT findings (num-
ber and evolutive stages of lesions) with prognostic
factors such as epilepsy duration, seizure frequency
before and after AED introduction, number of AED,
seizure control and seizure recurrence. In univaried
analysis, we did not find any correlation among them.
When isolated, neither number of parasites nor their
stages are predictive factors of outcome. In this se-
ries, we observed seizure-free patients with multiple
lesions in contrast to patients with refractory epi-
lepsy with few lesions.
One limitation of our research is the low number
of patients, which is due to the rigid inclusion crite-
ria. However, out of 12 analyzed factors, only two
showed borderline findings: number of lesions with
recurrence (p=0.08) and number of lesions with
number of AED (p=0.06). If number of patients were
higher, there would be a chance that statistical analy-
sis could show different data of the two variables
described above. Some authors found that patients
with calcified lesions in large number have a worse
prognosis, while other authors have different point
of view9,17,18.
The poor understanding of the pathophysiology
of the seizures due to NC parallels difficulties in ex-
plaining the variability of clinical manifestations7,19.
Particularly in childhood, presentation may vary from
“benign” to severe epileptic syndromes, such as Len-
nox-Gastaut syndrome10,20,21. Some factors that may
contribute to explain this variability are: spontane-
ous resolution of the lesions; persistence of perilesio-
nal edema around calcified lesions; unpredictable
evolution of the parasite that allows the coexistence
of different forms in the same subject; the immune
response of the host; and, the environment in which
the child lives that may be responsible for new in-
festations15,22-25.
The severity of clinical manifestation has also been
correlated to HLA antigens in the surface of the para-
sites, which suggests a genetic influence in the pre-
sentation of NC. Del Bruto25 found higher rates of
HLA 28 in patients with NC when compared to con-
trols. Another antigen, DQW2, may be related to the
resistance of the disease. Therefore, an individual
predisposition to develop parenchymal NC is likely
to occur and could in part explain the variability of
the clinical expression.
We conclude that the course of epilepsy due to
NC in childhood cannot be based exclusively on the
number or stage of the parasites. Patients with mul-
tiple lesions will not necessarily present more sei-
zures or need more drugs than the others. Intrinsic
characteristics of the parasites as well as immunege-
netic aspects may play important role in the expla-
nation of the pleomorphic and unpredictable course
of the clinical picture.
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